White Paper: Understanding Clinical Outcome Assessments
One of the most significant recent developments in healthcare and the Life Sciences industry is the growing use of Clinical Outcome Assessments, or COAs. This paper aims to provide some background on COAs, explore the current state of initiatives underway to help guide biopharmaceutical companies and identify study design factors to consider relative to COA use in clinical studies. Register to download the paper to learn more.

By submitting this form, you consent to receive communications from PAREXEL.
Click here to customize your preferences or opt-out.

©2018 PAREXEL International Corp.
195 West Street Waltham, MA, 02451, USA • Tel: +1 781-487-9900
Privacy Policy | EU-US Privacy Shield Notice | Contact Us